Announcements

Intimation about meeting of analysts / representatives of different fund houses with Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, between 2.00 P.M.and 5.00 P.M. on Thursday, September 07, 2017, at our office.

Intimation about meeting of Mr. Rakesh Nayudu, Analyst- Healthcare, of Haitong Securities India Private Limited, and his team with Mr. Sachin Salvi, General Manager-Finance, by 10.00 A.M. on Friday, September 08, 2017, at our office.

Intimation about participation of Mr.Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Strategy & Development, in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Wednesday, September 06, 2017.

Intimation about change in the Board of Directors, i.e. appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the retiring director, who had expressed his intention not to seek reappointment.

Intimation about the post-quarterly results conference call scheduled to be held at 3.00 p.m. on Monday,21-08-2017.

An update of the 17th Annual General Meeting of the Company held on 12-08-2017 and the resolutions passed thereat.

Intimation about decisions taken at the Board Meeting held on August 12, 2017, about approval of the Unaudited Financial Statements (both Stand-alone and Consolidated) for the quarter ended 30-06-2017, as per IND-AS Standards.

Intimation about Board Meeting scheduled to be held on August 12, 2017 to approve unaudited financial statements (both Stand-alone and Consolidated) for the quarter ended June 30, 2017.

Intimation about notice received from a shareholder proposing appointment of Dr. Indumati Gopinathan as a Director in the place of Mr. Sohil Chand, the director liable to retire at the ensuing AGM to be held on 12-08-2017, who has expressed his intention not to seek reappointment.

Intimation about 17th Annual General Meeting convened to be held on 12-08-2017 at 10.30 A.M. , Book-Closure for payment of final dividend of Rs.5/- (on approval by shareholders), & e-voting facility available to the Shareholders.

Intimation about meeting of Mr. Naveen Baid, Senior Analyst and Mr. Avinash Nahata, Head-Fundamental Equity Desk, of Aditya Birla Money Ltd., and their team with our General Manager-Finance, Mr. Sachin Salvi, by 4.00 P.M. on Thursday, June 29, 2017, at our office.

Intimation about meeting of:
(i)Mr. Eric Jones, Portfolio Manager of Dragoneer Investment Group, U.S., with our Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 2.00 P.M. on Tuesday, June 27, 2017, at our office. The meeting is arranged by J M Financial Institutional Securities Ltd., Mumbai.
(ii)Mr. Vikas Gattani, CIO (based in Singapore) of Progress India Opportunities Fund, Mumbai, with our Vice-President (Operations), Dr. Caesar Sengupta and Head (Strategy and Corporate Development), Mr. Vatsal Goyal, by 9.30 A.M. on Wednesday, June 28, 2017, at our office.

Intimation about: Meeting of Mr. H. Sangameswar Iyer, V.P. Investments, Shubhkam Ventures, with our General Manager-Finance, Mr. Sachin Salvi, and Head – Strategy & Corporate Development, Mr. Vatsal Goyal, by 11.00 A.M. on Wednesday, June 21, 2017, at our office.

Intimation about: Meeting of Mr. Lukas Davies, Barca Capital USA, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head – Nueclear Operations, by 10.00 A.M. on Monday, June 19, 2017, at our office.

Intimation about:
Meeting of one Group of Investor with our Chairman & Managing Director, Dr. A. Velumani, by 10.00 A.M., at our office on Thursday, June 15, 2017, arranged by New Horizon Fund; and
Meeting of the following investors with our Chairman & Managing Director, Dr. A. Velumani in the afternoon, arranged by Centrum at their office.

Intimation that as the final dividend is subject to approval of members, the provision made therefor has been revised, resulting in increase of Rs.323.30 Million in Reserves & Surplus and decrease of similar amount from Short-term provisions. The revised Audited Financial Statements (both Stand-alone and Consolidated), are provided under Financial Statements.

Intimation about meetings of
Mr. Sudarshan Padmanabhan, Analyst, Sundaram Mutual Fund, with our Vice-President, Dr. Caesar Sengupta, General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 10.00 A.M. on Thursday, June 08, 2017, at our office.
Mr. Thomas Mobille, Director/Senior Analyst, Limiar Capital Management, USA, with our General Manager-Finance, Mr. Sachin Salvi, and Mr. Vatsal Goyal, Head–Nueclear Operations, by 4.00 P.M. on Thursday, June 08, 2017, at our office.

Intimation about Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head – Nueclear Operations, participating at an investor conference organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident, BKC, on 7th June 2017, where the following fund managers will participate.

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place from 5th to 8th June 2017, during his visit to Hong Kong and Singapore

Intimation about participation of our Chairman & Managing Director, Dr. A. Velumani, in an investor conference on 30th May, 2017 at Hotel Sofitel, BKC, Mumbai, an open session attended by global / domestic institutional investors / fund houses, etc., being arranged by Phillip Capital.

Intimation about conference call on 11-05-2017 about the Audited financial results for the quarter / whole year ended March 31, 2017

Intimation about decisions taken at the Board Meeting held on May 09, 2017, about approval of the Audited Financial Statements (both Stand-alone and Consolidated), Granting of Stock Options to the Employees for the FY 2016-17 and recommending a final dividend of Rs.5/- per share, which is in addition to the interim dividend of Rs. 5/- already paid. With this, the total dividend for the year would be 100%.

Intimation about Board Meeting scheduled to be held on May 09, 2017 to approve audited financial statements (both Stand-alone and Consolidated) for FY 2016-17 and to consider granting of Stock Options to eligible employees for FY 2016-17.

Intimation about meeting of the representatives of various funds, as follows, with our Chairman & Managing Director, Dr. A. Velumani, scheduled to take place on 26th & 27th April 2017 during his visit to UK.

Intimation about meeting of Mr. Mahesh Natarajan of ICICI Securities and Mr. Shriraam Rathi, ISec Healthcare Research Analyst, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 9.30 a.m. at our office.

Intimation about meeting of Analysts from Falcon Edge, Comgest, Goldman Sachs, PineBridge, East Bridge and a few other Investors, with our Chairman & Managing Director, Dr. A. Velumani on Monday, April 10, 2017 by 11.00 a.m., followed by a visit to our central Processing Laboratory at Navi Mumbai.

Intimation about meeting of Mr. Anmol Ganjoo, of J M Financial, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Friday, April 07, 2017, by 10.00 A.M.

Intimation about meeting of Mr. Abhishek Thepade, Fund Manager of DNB Nor, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Wednesday, March 29, 2017 by 10.00 A.M

Intimation about the following decisions taken at the Board Meeting held on March 24, 2017, subject to approval of Members wherever necessary:
(i) To reappoint Dr. A. Velumani as Managing Director & CEO for 3 years from 01-04-2017 on a token salary of Re. 1/- per month as chosen by him.
(ii) To reappoint Mr. A. Sundararaju as Executive Director & CFO for 3 years from 01-04-2017 on the same salary of Rs. 5 lakhs per month.
(iii) To acquire the trademark “Whaters” from Dr. A. Velumani, Chairman & Managing Director, who offered to assign the same to the Company for a token consideration of Re. 1/- and the trademark “Nueclear” to NHL, the wholly owned subsidiary, for a similar token consideration of Re. 1/-, and also waive the royalty due to him from both the companies for usage till now.
(iv) To give loan to NHL, the wholly owned subsidiary, at arm’s length basis, to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc. for setting up additional scanning centres.

Intimation about meeting of Mr. Rahul Gupta, Investment Analyst, of Fidelity International, with our General Manager-Finance, Mr. Sachin Salvi at our Corporate Office, Turbhe, Navi Mumbai, on Thursday, March 23, 2017 by 10.30 A.M.

Intimation about change in timing of Conference Call between Mr. Anubhav Aggarwal, Healthcare Analyst from Credit Suisse and our General Manager- Finance, Mr. Sachin Salvi, on Wednesday, March 08, 2017 as 3.30 P.M., where some other analysts/investors might also join.